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Edited by Ned ManteiAbstract We show that a glycerophosphodiester phosphodies-
terase homolog, GDE2, is widely expressed in brain tissues
including primary neurons, and that the expression of GDE2 in
neuroblastoma Neuro2A cells is signiﬁcantly upregulated during
neuronal diﬀerentiation by retinoic acid (RA) treatment. Stable
expression of GDE2 resulted in neurite formation in the absence
of RA, and GDE2 accumulated at the regions of perinuclear and
growth cones in Neuro2A cells. Furthermore, a loss-of-function
of GDE2 in Neuro2A cells by RNAi blocked RA-induced neurite
formation. These results demonstrate that GDE2 expression
during neuronal diﬀerentiation plays an important role for grow-
ing neurites.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Escherichia coli (E. coli) glycerophosphodiester phosphodies-
terases (GP-PDEs), GlpQ and UgpQ, are periplasmic and cyto-
solic proteins, which play an important role in the hydrolysis of
deacylated glycerophospholipids to glycerol phosphate and
alcohol, which are utilized as amajor source of carbon andphos-
phate in E. coli [1,2]. In contrast, two novel mammalian GP-
PDEs, GDE1/MIR16 and GDE3, were recently identiﬁed, and
considered to be involved in several physiological functions
[3,4]. GDE1/MIR16 was identiﬁed by yeast two-hybrid screen-
ing as a protein interactingwithRGS16, a regulator ofGprotein
signaling [3]. A recent study has shown that GDE1 is an integral
membrane-bound glycoprotein that selectively hydrolyzes glyc-
erophosphoinositol (GroPIns) [5]. In addition, Zheng et al. dem-
onstrated thatGroPIns phosphodiesterase activity inHEK293T
cells can be regulated by stimulation of G protein-coupled a/b-
adrenergic and lysophospholipid receptors [5]. Also, GDE3 was
recently identiﬁed to be diﬀerentially expressed during speciﬁc
stages of diﬀerentiation in mouse osteoblast-like MC3T3-E1
cells using a diﬀerential display method [4]. GDE3 encodes aAbbreviations: GP-PDE, glycerophosphodiester phosphodiesterase;
RA, retinoic acid; GFP, green ﬂuorescent protein; DMEM, Dulbecco’s
modiﬁed Eagle’s medium; FCS, fetal calf serum
*Corresponding author. Fax: +81 82 424 7916.
E-mail address: yanaka@hiroshima-u.ac.jp (N. Yanaka).
0014-5793/$32.00  2007 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2007.01.035protein with seven putative transmembrane regions and an
extracellular loop containing a GP-PDE domain. We demon-
strated that GDE3 protein accumulates at the cell periphery,
and that overexpression ofGDE3 changes transfected cells from
a spread to a rounded form [4]. Moreover, endogenous GDE3
was co-localized with actin ﬁlament inMC3T3-E1 cells, suggest-
ing that GDE3 is involved in the morphological change of cells
accompanyingmodiﬁcation of the cytoskeleton. Thus, mamma-
lian GP-PDEs are considered to be involved in numerous
physiological functions including signal transduction and cyto-
skeletal regulation.
Very recently, six mammalian GP-PDEs have been virtually
cloned by an approach using bioinformatics [5,6]. In particular,
we showed that GDE2 contained 607 amino acids with seven
putative transmembrane regions, and that it was 43.7% identi-
cal to GDE3 at the amino acid level. Although GDE3mRNA is
restrictedly expressed in bone tissue and in the spleen, GDE2
mRNA was highly expressed in mouse brain, suggesting that
GDE2 might have distinct roles in the nervous system. The
physiological function of the nervous system is tightly associ-
ated with the highly speciﬁc pattern of connections formed be-
tween neurons. The speciﬁcity of these connections requires
neurite extension toward their targets guided by the growth
cone [7–9]. Ever since we showed that GDE3 protein was local-
ized at the cell periphery and played a critical role for morpho-
logical change of cells, we have been particularly interested in
the biological functions of mammalian GP-PDEs in neurons.
These observations led us to hypothesize that GDE2might play
critical roles for neurite formation and/or neurite retraction.
Neuro2A cells are neuroblastoma established from the mouse
spinal cord, and are widely used for studies on neurite growth
that is induced by retinoic acid (RA) treatment. Although sev-
eral molecules have been reported to be involved in retinoid-in-
duced neuronal diﬀerentiation of Neuro2A cells [10–12], our
understanding of the mechanisms involved in the control of
neuronal diﬀerentiation of Neuro2A cells remains limited. In
this study, we demonstrated that the expression of GDE2 was
dramatically upregulated during neuronal diﬀerentiation in re-
sponse to RA, and that GDE2 played a critical role for neurite
outgrowth of Neuro2A cells.2. Materials and methods
2.1. Materials
Restriction endonucleases and DNA-modifying enzymes were pur-
chased from Takara Shuzo (Kyoto, Japan). Murine neuroblastoma
Neuro2A cells were obtained from Health Science Research Resourcesation of European Biochemical Societies.
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calf serum (FCS) were purchased from Invitrogen. Antibodies speciﬁc
for ERK1 and ERK2 were products of Santa Cruz Biotechnology.
Anti-phospho-ERK1/2 antibody was obtained from Cell Signaling.
Anti-GDE2 antibody was generated as we previously described [6].
2.2. Cell culture and transfection
Neuro2A cells were cultured in DMEM supplemented with 10%
FCS, 100 units/ml penicillin, and 100 lg/ml streptomycin under a
humidiﬁed atmosphere of 5% CO2 in air at 37 C. The cells were
seeded at 3.0 · 104 and incubated for 24 h in a 90 mm-diameter plastic
Petri dishes. Then induction of neuritogenesis was performed as previ-
ously described [13,14]. Brieﬂy, diﬀerentiation was initiated by admin-
istration of 20 lM RA (Nacalai Tesque, Japan) in DMEM
supplemented with 2% FCS. The open reading frame of GDE2 was
digested with BamHI, followed by blunting with T4 DNA polymerase.
pEGFP-N1 (Clontech) was digested with XhoI, followed by blunting
with T4 DNA polymerase. The resultant two DNA fragments were
digested with KpnI and ligated, generating pEGFP-GDE2. Neuro2A
cells were transiently transfected with pEGFP-GDE2 using Lipofect-
AMINE 2000 (Invitrogen), according to the manufacturer’s instruc-
tions. After transfection into Neuro2A cells, the cells were treated
with 500 lg/ml of G418 for 14 days. After G418-resistant colonies were
isolated, independent colonies were re-seeded in the growth medium,
respectively. The morphology of each cell line was observed under a
microscope, and photographs were taken at 100· magniﬁcation. To
quantitatively evaluate neuritogenesis, the 80 diﬀerentiated cells were
counted in ﬁve randomly chosen ﬁelds of each dish. Cells bearing neu-
rites at least 1.5-fold longer than the soma diameter were regarded as
being diﬀerentiated. pGFP-GDE2 was digested with both EcoRI and
NotI, and insert fragment was ligated to EcoRI and NotI sites of the
pMX retrovirus vector. High titer retroviruses harboring GDE2-
GFP were produced in Phoenix 293 cells, and used to infect Neuro2A
cells, as reported previously [15]. After Neuro2A cells were grown on
glass slides with chamber polystyrene vessels in DMEM containing
10% FCS, they were directly ﬁxed with 4% paraformaldehyde in phos-
phate-buﬀered saline (PBS) for 30 min. Subsequently, the cells were
washed for 10 min in PBS with 0.1% Tween 20, treated with rhodamine
phalloidin (Molecular Probes) for 1 h, and visualized by ﬂuorescence
microscopy.
Primary cortical neurons and primary glial cells from mouse fetuses
were isolated as we described previously [16]. Expression of GDE2Fig. 1. Expression of GDE2 mRNA in a variety of brain regions and neuron
Northern blot analysis. Expression of GDE2 mRNA was observed in ad
hippocampus, and hypothalamus. (B) Expression of GDE2 mRNA in p
particularly abundant in primary neuronal cells. (C) Neuronal diﬀerentiation o
total RNA from Neuro2A cells cultured at the indicated time was subjected to
were normalized by that of the b-actin. Results are expressed as the fold-incr
(D) GDE2 protein is upregulated during diﬀerentiation of Neuro2A cells. Me
gels were analyzed by Western blot with anti-GDE2 antibody. Expression ofmRNA in these cultures was examined using RT-PCR with primers
5 0-CCGCCATGCTGGCGCTCATCTC-3 0 and 5 0-AGGTCTCAGC-
TTCTCCGGGATT-3 0.
2.3. Small Interfering RNAs (siRNAs)
Duplex siRNAs with a two nucleotide overhang at the 3 0-end of the
sequence were designed at iGENE Therapeutics and synthesized at
Hokkaido System Science Co., Ltd. The target sequence was as
follows: GDE2, CCUGCAUCAUGGAGAAAAAAGACCU. Neu-
ro2A cells were transfected with siRNAs in a ﬁnal concentration of
20 nM and pEGFP-N1 using LipofectAMINE 2000. At 8 h post-trans-
fection, diﬀerentiation was initiated by administration of 20 lM of
RA. The morphology of the cells was observed under a microscope,
and photographs were taken at 100· magniﬁcation. To quantitatively
evaluate neuritogenesis, neurite lengths of eighty GFP-positive cells in
ﬁve randomly chosen ﬁelds of each dish were measured.
2.4. Western blot analysis
Neuro2A cells were washed with ice-cold PBS, and scraped in ice-
cold RIPA buﬀer (10 mM Tris–HCl, pH 7.4, 1% NP-40, 0.1% sodium
deoxycholate, 0.1% SDS, 0.15 M NaCl, 1 mM EDTA). The homoge-
nates were centrifuged at 10000 · g for 10 min. Protein concentration
of the supernatant was determined using the Bio-Rad protein assay kit
(Bio-Rad) with BSA as a standard. Ten micrograms (protein equiva-
lents) of the supernatant were subjected to SDS–PAGE and trans-
ferred to an Immobilon P ﬁlter (Millipore). The ﬁlter was blocked
for 18 h at 4 C by soaking in 4% non-fat dried milk (Nacalai Tesque,)
in PBS and was incubated for 18 h at 4 C with anti-GDE2 antibody
(diluted 1:1000). Signals were detected using horseradish peroxidase-
conjugated anti-rabbit IgG and the enhanced chemiluminescence sys-
tem (Amersham Bioscience).
2.5. Northern blot analysis
Total RNAs were isolated using ISOGEN (Nippon gene, Toyama,
Japan), and fractionated in a 1% agarose gel containing 0.66 M form-
aldehyde and 0.02 M MOPS (pH 7.0). Fractionated RNAs were
transferred onto a nylon ﬁlter by capillary blotting and then cross-
linked by ultraviolet irradiation. 32P-labeled cDNA fragments encod-
ing mouse GDE2, human glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), and human b-actin were used as probes for Northern blot-
ting hybridization. Hybridization was performed in 6· SSC, 0.5% SDS,al cells. (A) Ten lg of total RNAs from brain regions were subjected to
ult mouse brain regions, including the cerebral cortex, cerebellum,
rimary neurons (Neuron) and glia cells (Glia). GDE2 mRNA was
f Neuro2A cells was initiated by administration of 20 lMRA. 10 lg of
Northern blot analysis. The total densities of the GDE2 mRNA bands
ease in GDE2 mRNA relative to Neuro2A cells in the absence of RA.
mbrane fraction of Neuro2A cells were subjected to SDS–PAGE. The
GDE2 protein is upregulated during diﬀerentiation of Neuro2A cells.
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for 16 h with the probe. The membrane was washed with 0.1· SSC
and 0.5% SDS at 65 C for 1 h and exposed to an imaging plate.Fig. 2. Expression of GDE2 mRNA in Neuro2A cells. Diﬀerentiation
and neuritogenesis of Neuro2A cells were induced by administration of
20 lM of RA (A), 10 lM of ganglioside GM1 (B), or 10 lM of
cytosine arabinoside (C). 10 lg of total RNA from Neuro2A cells
cultured at the indicated time was subjected to Northern blot analysis.3. Results
3.1. Expression of GDE2 mRNA in mouse brain and
Neuro2A cells
Northern blot analyses were performed using total RNAs
from mouse brain and Neuro2A cells, and the GDE2 cDNA
fragments as probes. A 3.7 kb GDE2 mRNA was widely
expressed in the adult mouse brain, including the hippocampus,
cerebellum, cerebral cortex, and hypothalamus (Fig. 1A). Fur-
thermore, to identify the cell types in whichGDE2mRNA is ex-
pressed, we isolated primary cortical neurons and primary glial
cells from mouse fetuses. The expression of GDE2 mRNA in
these cultures was examined using RT-PCR with primers spe-
ciﬁc to GDE2 cDNA, showing that GDE2 mRNAwas particu-
larly abundant in primary neuronal cells (Fig. 1B). Mouse
neuroblastomaNeuro2A cells have served as a usefulmodel sys-
tem for the study of neuronal diﬀerentiation and morphology.
When Neuro2A cells are exposed to RA for 1–2 days, they ac-
quire many features of sympathetic neurons, such as an
outgrowth of neurites. To investigate the role of GDE2 in
neuronal cell morphology, we examined whether RA inﬂu-
ences the GDE2 mRNA expression in Neuro2A cells. Total
RNA was extracted from Neuro2A cells cultured in the
presence of 20 lM of RA for 0, 1, 2, 6, 14, and 26 h. Fig. 1C
showed that treatment of Neuro2A cells with RA resulted in a
signiﬁcant increase in the GDE2 mRNA level, and that GDE2
mRNA level peaked at 3–6 h and decreased thereafter. Two dis-
crete GDE2 mRNA species (3.7 and 2.9 kb) were observed in
Northern blot analyses. We have previously isolated two diﬀer-
ent sized cDNAs corresponding to mouse GDE2 mRNA (data
not shown), revealing the presence of two diﬀerent species of
mouse GDE2 mRNA. The long transcript of GDE2 was dom-
inant in mouse brain tissues. When using GDE3 cDNA as a
probe, no hybridization signal was observed with and without
RA treatment (data not shown). Western blot analysis showed
that theGDE2 protein level was upregulated at 24 h in themem-
brane fraction of Neuro2A cells (Fig. 1D).
Next, we were interested in the mechanism underlying the
upregulation of GDE2 mRNA expression in Neuro2A cells. AFig. 3. Intracellular localization of GDE2 protein in Neuro2A cells. Retrov
terminus (GDE2-GFP) were used to infect Neuro2A cells (A). Actin ﬁlaments
ﬂuorescence microscopy. GDE2-GFP accumulated at the regions of perinucprevious report showed that diﬀerentiation and neuritogenesis
of Neuro2A cells were induced by exogenously added
ganglioside GM1 [17]. A previous report by Prinetti et al. [18]
demonstrated that c-src protein was accumulated in a
glycosphingolipid-enriched microdomain of Neuro2A cells by
GM1 treatment, suggesting that the molecular mechanism of
neuronal outgrowth is diﬀerent for treatment with RA vs.
GM1. To determine whether the upregulation of GDE2mRNA
expression is dependent on neuronal diﬀerentiation per se, we
examined the eﬀect of exogenously added GM1 on GDE2
mRNA expression. In this experiment, GM1 was shown to be
able to induce neurite formation (data not shown), but showediruses harboring GDE2 with green ﬂuorescent protein fused to the C
were stained with rhodamine phalloidin (B), followed by analysis using
lear and growth cones (arrows) in Neuro2A cells.
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was again induced as expected in the control experiment with
RA (Fig. 2A). Moreover, because RA-primed neural diﬀerenti-
ation ofNeuro2A cells was performed in amediumwith low ser-
um, we could not exclude the possibility that GDE2 mRNA
expression is upregulated by growth arrest of Neuro2A cells.
However, arabinosylcytosine (Fig. 2C) or cultivation without
serum (data not shown) did not inﬂuence GDE2mRNA expres-
sion, indicating that the increased expression of GDE2 mRNA
inNeuro2A cells was dependent not on growth inhibition but on
RA. In order to address the intracellular localization of GDE2
protein, we infected Neuro2A cells with retroviruses harboringA
D
B M G5
N
eu
ri
te
le
ng
th
 (
m
)
μ
C
M G5 G8
GDE2
-actinβ
0
20
40
60
80
*
*
*
G5 G8M M
RA
+
Fig. 4. Overexpression of GDE2 promotes neuronal outgrowth. After tran
expressing the full-length protein were constructed as described in Section 2. (A
vector-transfected cells (M) cultured in the absence of RA were subjected to N
the absence of RA was observed under a microscope, and photographs were
longer than the soma diameter were regarded as being diﬀerentiated cells as
(M). (D) Neurite lengths were measured in each cell in randomly chosen ﬁelds
mock cell treated with RA for 24 h (M + RA). *P < 0.05 compared with t
signiﬁcance was determined by unpaired Student’s t test.GFP-fused GDE2. Analysis using ﬂuorescence microscopy
after visualization of actin ﬁlaments with rhodamine phalloidin
demonstrated that GDE2-fused GFP was concentrated at the
perinuclear region and also observed at growth cones (Fig. 3).
Wild-typeGFPwas distributed evenly over the entire cytoplasm
in Neuro2A cells when transfected with plasmid DNA encoding
the wild-type GFP (data not shown).
3.2. Constitutive expression of GDE2 dramatically promotes
neuronal outgrowth of Neuro2A cells
Because both GDE2 mRNA and protein were expressed
during RA-induced diﬀerentiation of Neuro2A cells, we0
10
20
30
40
M G5 G8
R
at
io
 o
f N
eu
ro
2A
 ce
lls
 
be
ar
in
g 
ne
ur
ite
(%
)
*
**
G8
sfection with pGFP-GDE2 into Neuro2A cells, Neuro2A cells stably
) 10 lg of total RNA from two positive clones (G5 and G8) and empty
orthern blot analysis. (B) The morphology of each cell line cultured in
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716 N. Yanaka et al. / FEBS Letters 581 (2007) 712–718investigated whether Neuro2A gene expression could alter the
program of neuronal diﬀerentiation. These cells were stably
transfected with the full-length coding region of GDE2 or with
the mock vector. As shown in Fig. 4A, a signiﬁcant elevation
of GDE2 mRNA was observed in two stably transfected
clones, G5 and G8, in the absence of retinoic acid, but not
in the mock clone M. After neurite lengths were measured in
each cell in randomly chosen ﬁelds of each clone, cell number
bearing neurites at least 1.5-fold longer than the soma diame-
ter was counted. Constitutive expression of GDE2 increased
the number of cells bearing neurites in the absence of RA (with
1.8- and 2.8-fold increases, respectively) and also increased
neurite lengths (with 1.9- and 2.4-fold increases, respectively),
compared with the mock M clone (Fig. 4B–D). These results
were consistent with the expression level of GDE2.GDE2 RNAiscramble
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Fig. 5. Eﬀects of GDE2 siRNA on neurite formation of Neuro2A
cells. Neuro2A cells were transfected with scrambled siRNA (scram-
ble) or GDE2 siRNA (GDE2 siRNA) with pEGFP and then
stimulated with 20 lM of RA. After treatment with RA for 24 h,
10 lg of total RNA was subjected to Northern blot analysis. (B) The
morphology of these cells cultured in the presence of RA for 48 h was
observed under a microscope, and photographs were taken at 100·
magniﬁcation. (C) After treatment with RA for 24 or 48 h, neurite
lengths were measured in each GFP-positive cell in randomly chosen
ﬁelds of each dish. *P < 0.05 compared with those of cells transfected
with scramble siRNA. Values are expressed as means ± S.E. Statistical
signiﬁcance was determined by unpaired Student’s t test.3.3. Eﬀects of GDE2 siRNA on neurite formation of Neuro2A
cells
To investigate roles of GDE2 in neurite formation, we ﬁnally
tried to examine the eﬀects of GDE2 siRNA on RA-induced
neuronal outgrowth of Neuro2A cells. These cells were trans-
fected with GDE2 siRNA or scrambled siRNA (scramble)
together with a plasmid carrying GFP cDNA and then stimu-
lated with RA. After treatment with 20 lM of RA for 24 h or
48 h, neurite lengths were measured in each GFP-positive cell
in randomly chosen ﬁelds of each dish. GDE2 RNAi gene
silencing, which resulted in a strong reduction of mRNA
expression (Fig. 5A), signiﬁcantly reduced the extent of neurite
outgrowth in Neuro2A cells after RA treatment for 24 h and
48 h (by 50.4% and 34.2%, respectively) (Fig. 5B and C). Pre-
vious work by Singh et al. has shown that a MAP kinase path-
way including ERK1/2 was activated during RA-induced
neuronal diﬀerentiation of neuroblastoma SH-SY5Y cells
[19]. Although the current study showed that RA could pro-
mote ERK1/2 activation in Neuro2A cells (Fig. 6A), knock-
down of GDE2 in Neuro2A cells by RNAi did not inﬂuence
ERK1/2 activation by RA, as shown in Fig. 6B.4. Discussion
RA is well known to play critical roles in nervous system
development, including neuronal patterning and neurite out-
growth [20]. In particular, RA is demonstrated to induce neu-
rite outgrowth from spinal cord, dorsal root ganglia neurons,
and neuroblastoma cells [13,21,22]. One mechanism whereby
RA aﬀects neurite extension was previously shown to be by
regulating the expression of neurotrophin receptors includingFig. 6. Eﬀect of GDE2 siRNA on the activation of ERK induced by
RA in Neuro2A cells. (A) Total lysates from Neuro2A cells were
prepared after stimulation with RA for the indicated time, and
subjected to Western blot analyses using antibody speciﬁc for
phosphorylated form of ERK1/2 (upper panel). The same membrane
was re-blotted with anti-ERK1/2 antibody (lower panel). (B) Neuro2A
cells were transfected with scrambled siRNA (scramble) or GDE2
siRNA (GDE2 siRNA), and then stimulated with 20 lM of RA. Cell
lysates from Neuro2A cells were prepared after stimulation with RA
for the indicated time, and subjected to Western blot analyses as
described above.
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that a number of mRNAs are identiﬁed to be rapidly induced
by RA in SH-SY5Y and Neuro2A cells [24,25]. Merrill et al.
have reported that expression of 14 genes is rapidly upregu-
lated by RA treatment in SH-SY5Y cells, and that mRNAs
encoding candidate neurite regulating factors including ephrin
B2 and a novel Rho GTPase-activating protein family member
are induced by RA [24]. An interesting recent report has
revealed that 38 genes change their expression rapidly after
RA treatment in Neuro2A cells [25]. Among them, the expres-
sion pattern of 6 genes, including Gse1 and Garn14, is similar
to that of GDE2, suggesting that they might collaborate with
GDE2 to trigger neurite outgrowth.
GDE2 has been virtually cloned by an approach using bioin-
formatics as a membrane protein with an extracellular loop
containing a GP-PDE domain [5,6]. A recent work by Zheng
et al. demonstrated that GDE1 could selectively hydrolyze
GroPIns, indicating that GDE1 might play physiological roles
through the hydrolysis of GroPIns and/or some of its phospho-
lyrated derivatives such as glycerophosphoinositol 4-phosphate
(GroPIns4P) [5]. GroPIns and GroPIns4P are water-soluble
phosphoinositide metabolites and were originally reported to
be associated with the expression of oncogenic Ras [26]. Man-
cini et al. showed the remarkable eﬀects of GroPIns4P on the
reorganization of actin cytoskeleton in Swiss 3T3 cells, demon-
strating that exogenously added GroPIns4P potently induces
the formation of membrane ruﬄes and stress ﬁbers via the acti-
vation of two small G-proteins, Rac and Rho [27]. Addition-
ally, we previously demonstrated that GDE3 was co-localized
with actin ﬁlaments and that GDE3 induced morphological
change in cells when overexpressed [4]. Following the proposal
that a rearrangement of actin ﬁlaments in growth cones is
essential for neuronal outgrowth and polarity [28,29], it was
further suggested that GP-PDEs are involved in the morpho-
logical change of neuronal cells through actin remodeling by
regulation of GroPIns and/or GroPIns4P levels. Previous re-
ports have implicated the Rho family of small G-proteins,
Rho, Rac and Cdc42 in the regulation of neurite outgrowth
and patterning. Importantly, several studies have shown that
Rac1 and Cdc42 have a signiﬁcant role in neuronal diﬀerentia-
tion and neurite outgrowth [30,31]. These observations suggest
that a mechanism whereby GDE2 plays a role for neurite exten-
sion might be by regulating the Rac1 and/or Cdc42 signaling
via the regulation of GroPIns/GroPIns4P level.
On the other hand, non-genomic actions of RA have been
recently proposed. RA has been shown, in some cases, to rap-
idly activate kinase signaling cascades. Singh et al. have shown
that tissue transglutaminase mediates activation of the MAP
kinase pathway including ERK1/2, JNK1 and p38 kinases dur-
ing RA-induced neuronal diﬀerentiation of SH-SY5Y cells
[19]. Additionally, a recent work by Evangelopoulos et al.
has demonstrated that ERK1/2 is activated in Neuro2A cells
in response to serum withdrawal [32]. In our study, RA was
shown to promote ERK1/2 activation in Neuro2A cells.
Knockdown of GDE2 in Neuro2A cells by RNAi did not
inﬂuence ERK1/2 activation by RA, indicating that the phy-
siological action of GDE2 is not dependent on ERK1/2 signal-
ing.
During the course of the current study, Rao et al. have dem-
onstrated that GDE2 is necessary to drive spinal motor neuron
diﬀerentiation in vivo [33]. Although information about the
control of neurite extension of Neuro2A cells remains unclearat the molecular level, the current study demonstrated a critical
role of GDE2 for retinoid-induced neuronal outgrowth. Fur-
ther investigations are needed to resolve the molecular mecha-
nism of GDE2-mediated neuronal outgrowth.References
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